Sign inGet started

Rummelt Andreas

Insider CIK 1484986 · ALXN Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ALXN ALEXION PHARMACEUTICALS, I D To issuer deriv2021-07-212021-07-233,425$96.35 $330.0K0SEC↗
ALXN ALEXION PHARMACEUTICALS, I D To issuer deriv2021-07-212021-07-232,343$155.01 $363.2K0SEC↗
ALXN ALEXION PHARMACEUTICALS, I D To issuer deriv2021-07-212021-07-232,785$159.70 $444.8K0SEC↗
ALXN ALEXION PHARMACEUTICALS, I D To issuer deriv2021-07-212021-07-233,237$85.75 $277.6K0SEC↗
ALXN ALEXION PHARMACEUTICALS, I D To issuer deriv2021-07-212021-07-232,294$138.86 $318.5K0SEC↗
ALXN ALEXION PHARMACEUTICALS, I D To issuer2021-07-212021-07-2328,109— $00SEC↗
ALXN ALEXION PHARMACEUTICALS, I A Award2021-05-202021-05-24533— $028,109SEC↗
ALXN ALEXION PHARMACEUTICALS, I A Award2021-05-202021-05-241,962— $027,576SEC↗
ALXN ALEXION PHARMACEUTICALS, I A Award2020-05-142020-05-183,468— $025,614SEC↗
ALXN ALEXION PHARMACEUTICALS, I A Award2019-05-152019-05-172,726— $022,146SEC↗
ALXN ALEXION PHARMACEUTICALS IN A Award2018-05-092018-05-112,174— $019,420SEC↗
ALXN ALEXION PHARMACEUTICALS IN A Award2017-05-102017-05-122,030— $017,246SEC↗
ALXN ALEXION PHARMACEUTICALS IN A Award deriv2016-05-112016-05-132,294$138.86 $318.5K2,294SEC↗
ALXN ALEXION PHARMACEUTICALS IN A Award2016-05-112016-05-13835— $015,216SEC↗
ALXN ALEXION PHARMACEUTICALS IN A Award deriv2015-05-062015-05-082,343$155.01 $363.2K2,343SEC↗
ALXN ALEXION PHARMACEUTICALS IN A Award2015-05-062015-05-08700— $013,486SEC↗
ALXN ALEXION PHARMACEUTICALS IN M Exercise deriv2014-08-252014-08-271,393$49.43 $68.9K0SEC↗
ALXN ALEXION PHARMACEUTICALS IN M Exercise deriv2014-08-252014-08-273,659$24.36 $89.1K0SEC↗
ALXN ALEXION PHARMACEUTICALS IN S Sale2014-08-252014-08-275,052$170.53 $861.5K12,786SEC↗
ALXN ALEXION PHARMACEUTICALS IN M Exercise2014-08-252014-08-271,393$49.43 $68.9K17,838SEC↗
ALXN ALEXION PHARMACEUTICALS IN M Exercise2014-08-252014-08-273,659$24.36 $89.1K16,445SEC↗
ALXN ALEXION PHARMACEUTICALS IN A Award deriv2014-05-052014-05-072,785$159.70 $444.8K2,785SEC↗
ALXN ALEXION PHARMACEUTICALS IN A Award2014-02-282014-03-04895— $013,181SEC↗
ALXN ALEXION PHARMACEUTICALS IN A Award deriv2013-05-072013-05-093,425— $03,425SEC↗
ALXN ALEXION PHARMACEUTICALS IN A Award2013-02-062013-02-082,471— $012,786SEC↗
ALXN ALEXION PHARMACEUTICALS IN S Sale2012-07-272012-07-3110,000$107.00 $1.07M10,315SEC↗
ALXN ALEXION PHARMACEUTICALS IN S Sale2012-06-072012-06-0810,000$91.29 $912.9K20,315SEC↗
ALXN ALEXION PHARMACEUTICALS IN A Award deriv2012-05-082012-05-093,237— $03,237SEC↗
ALXN ALEXION PHARMACEUTICALS IN M Exercise deriv2012-02-232012-02-233,657— $03,659SEC↗
ALXN ALEXION PHARMACEUTICALS IN M Exercise2012-02-232012-02-233,657$24.36 $89.1K33,972SEC↗
ALXN ALEXION PHARMACEUTICALS IN S Sale2012-02-232012-02-233,657$84.96 $310.7K30,315SEC↗
ALXN ALEXION PHARMACEUTICALS IN M Exercise deriv2012-02-212012-02-232,786— $01,393SEC↗
ALXN ALEXION PHARMACEUTICALS IN M Exercise2012-02-212012-02-232,786$49.43 $137.7K33,101SEC↗
ALXN ALEXION PHARMACEUTICALS IN S Sale2012-02-212012-02-232,786$81.27 $226.4K30,315SEC↗
ALXN ALEXION PHARMACEUTICALS IN M Exercise2012-02-032012-02-063,115— $030,315SEC↗